Biotech

AVI BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results and Recent Corporate Developments

BOTHELL, WA: ...

Helix BioPharma Corp. Announces L-DOS47 Scientific Presentation to Be Made at the Second Annual IBC Conference on Analytical Technologies Biotherapeutic Development

AURORA, ON: ...

Biotie Successfully Completes Imaging Study With SYN120

TURKU, FINLAND: ...

Medivation Reports Fourth Quarter and Year-End 2011 Financial Results and Provides Corporate Update

SAN FRANCISCO, CA: Conference Call Today at 4:30 p.m. Eastern Time ...

Marina Biotech Presents Advances in Oral Delivery of Nucleic Acids at AsiaTIDES Conference in Tokyo

BOTHELL, WA: Company Also Presents Data on Liposomal Facilitation of Cell-to-Cell Transfer of Nucleic Acids ...

Pharma-Biotech Capital Construction Investment Snapshot: 2012 North American Project Starts Top $16 Billion, an Industrial Info News Alert

SUGAR LAND, TX: ...

Genetic Technologies Provides Update on U.S. and Australian Gene Patenting Litigation, Case Law and Legislation

MELBOURNE, AUSTRALIA: Developments Have No Impact on GTG's Global Business Operations ...

Arch Scientists to Lead Anti Corrosion Project for Auto Industry

TORONTO, ONTARIO: ...

AVI BioPharma Announces FDA Approval to Proceed With a Modified Dosing of AVI-6003 for Treatment of Marburg Virus

BOTHELL, WA: AVI-7288, a Component of AVI-6003, Shows Efficacy Results in Standalone Treatment of Non-Human Primate Studies ...

GeneWeave Biosciences Attracts $12 Million in Venture Capital in Round Financed by Decheng Capital, Claremont Creek Ventures and X/Seed Capital

SAN JOSE, CA: Capital Will Be Used to Complete the Development and Commercialization of the Company's First Molecular Diagnostic Product ...